SKIN Stock Price, Chart, Stats & News
SkinHealth Systems Inc. (SKIN) does not currently pay a dividend.
SKIN chart
Fundamentals
Gross margin | 65.26% |
Operating margin | -6.90% |
Pretax margin | -1.97% |
Net margin | -3.16% |
Effective tax rate | -60.46% |
ROA | -1.90% |
ROE | -15.42% |
D/E | 6.20x |
Interest coverage ratio | -1.07x |
SKIN valuation
P/E | – |
P/S | 0.34x |
P/B | 1.68x |
P/CF | 2.73x |
P/FCF | 2.83x |
P/OCF | 2.73x |
PEG | -0.69x |
EV multiple | -1.16x |
About
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health.
Similar securities
Based on sector and market capitalization
